Related Experiment Video
Updated: May 12, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Leveraging cancer genome information in hematologic malignancies
1Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Summary
Recent genetic studies have expanded knowledge of blood cancer alleles, improving prognostic models and understanding disease mechanisms. Challenges remain in applying these genomic discoveries to clinical practice and real-time decision-making.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Candidate gene and genome-wide studies have identified recurrent somatic disease alleles in hematologic malignancies.
- These discoveries are crucial for understanding the pathogenesis and transformation of hematopoietic cells.
Purpose of the Study:
- To review recent genetic advances in myeloid and lymphoid malignancies.
- To discuss the impact of these findings on prognostic models and clinical decision-making.
- To explore the implications of genomic discoveries for disease initiation and evolution.
Main Methods:
- Review of recent major genetic advances.
- Analysis of the impact on prognostic models and understanding of disease mechanisms.
- Discussion of genetic modeling concepts and current genetic investigation technologies.
Main Results:
- Expansion of knowledge on somatic disease alleles contributing to hematologic malignancies.
- Fundamental changes in developing prognostic schemas for outcome and therapeutic response.
- Substantive insights into hematopoietic transformation mechanisms.
Conclusions:
- Genetic discoveries have significant biologic and translational impact on hematologic malignancies.
- Challenges persist in applying genetic findings to clinical decision-making and implementing new technologies.
- Genomic insights are crucial for advancing patient care and understanding disease progression.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...